Evidence map›Paper›PMID 30805021›Full record

ArticleNutrition & metabolism2019

Role of

Qiantu Hu, Huafeng Chen, Yanli Zuo, Qin He, Xuan He, Steve Simpson, Wei Huang, Hui Yang, Haiying Zhang, Rui Lin

Open access · goldAbstract read
In one paragraph

Article in Nutrition & metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Qiantu Hu *1Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021 Guangxi China.
Huafeng Chen *2Guangxi Center for Disease Prevention and Control, Nanning, China.
Yanli Zuo *3General Practice School, Guangxi Medical University, Nanning, China.
Qin He2Guangxi Center for Disease Prevention and Control, Nanning, China.
Xuan He2Guangxi Center for Disease Prevention and Control, Nanning, China.
Steve Simpson4Melbourne School of Population & Global Health, University of Melbourne, Carlton, Australia.
Wei Huang2Guangxi Center for Disease Prevention and Control, Nanning, China.
Hui Yang2Guangxi Center for Disease Prevention and Control, Nanning, China.
Haiying Zhang1Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021 Guangxi China.
Rui Lin1Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021 Guangxi China.ORCID 0000-0002-3846-9301
Guangxi Center for Disease Prevention and Control · CNGuangxi Medical University · CNUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOil tea is a type of traditional tea beverage used for treating various ailments in minority population in Guangxi, China. Our previous study showed oil tea improved glucose and lipid levels in type 2 diabetic mice. Yet, the underling molecular mechanisms are still not understood. This study aimed at assessing the effect of oil tea on glucose homeostasis and elucidating the molecular mechanisms underlying the oil tea-induced antidiabetic effects.

methodsTwenty seven db/db mice were gavaged with saline, metformin and oil tea for 8 weeks with measurement of biochemical profiles. A real-time

resultsOil tea treatment facilitated glucose homeostasis by decreasing fasting blood glucose and total cholesterol, and improving glucose tolerance. Suppressing phosphoenolpyruvate carboxykinase 1 (

conclusionOur findings indicated oil tea improved glucose homeostasis via down-regulation of

Indexed as

Fasting blood glucoseGlucose toleranceGlycolysis/gluconeogenesis pathwayOil teaPCK1RT2 profiler PCR arraySNPType 2 diabetes

Identifiers

PMID30805021
PMCPMC6373102
OpenAlexW2925137215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.